Subscribe To
Alector, inc: a newer biotech company with big potential
Biotech companies have seen an economic boom lately thanks to the COVID-19 Pandemic and the need for effective ...
January 26, 2022, 5:47 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel ...
January 25, 2022, 8:43 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel ...
January 25, 2022, 8:43 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel ...
January 25, 2022, 8:43 am
Fda rescinds authorization for regeneron, eli lilly covid-19 antibody treatments: here's why
Antibody treatments made by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LL...
January 24, 2022, 10:28 pm
Fda rescinds authorization for regeneron, eli lilly covid-19 antibody treatments: here's why
Antibody treatments made by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LL...
January 24, 2022, 10:28 pm
Fda rescinds authorization for regeneron, eli lilly covid-19 antibody treatments: here's why
Antibody treatments made by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LL...
January 24, 2022, 10:28 pm
Fda rescinds authorization for covid antibody treatments by regeneron, eli lilly
Monoclonal antibody treatments by Regeneron and Eli Lilly proved ineffective against the omicron varian...
January 24, 2022, 6:38 pm
Fda rescinds authorization for covid antibody treatments by regeneron, eli lilly
Monoclonal antibody treatments by Regeneron and Eli Lilly proved ineffective against the omicron varian...
January 24, 2022, 6:38 pm
Fda rescinds authorization for covid antibody treatments by regeneron, eli lilly
Monoclonal antibody treatments by Regeneron and Eli Lilly proved ineffective against the omicron varian...
January 24, 2022, 6:38 pm
Angle says study shows parsortix can select patients most suitable for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed its Parsortix system could be used to select patients...
January 21, 2022, 3:30 am
Angle says study shows parsortix can select patients most suitable for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed its Parsortix system could be used to select patients...
January 21, 2022, 3:30 am
Angle says study shows parsortix can select patients most suitable for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed its Parsortix system could be used to select patients...
January 21, 2022, 3:30 am
Angle hails study where parsortix showed ability to help select patients for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed how its Parsortix system could be used to select patie...
January 21, 2022, 2:59 am
Angle hails study where parsortix showed ability to help select patients for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed how its Parsortix system could be used to select patie...
January 21, 2022, 2:59 am
Angle hails study where parsortix showed ability to help select patients for immunotherapy treatments
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed how its Parsortix system could be used to select patie...
January 21, 2022, 2:59 am
Cns pharmaceuticals to present at the virtual investor 2022 top picks conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in ...
January 20, 2022, 8:45 am
Cns pharmaceuticals to present at the virtual investor 2022 top picks conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in ...
January 20, 2022, 8:45 am
Cns pharmaceuticals to present at the virtual investor 2022 top picks conference
HOUSTON, Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in ...
January 20, 2022, 8:45 am
Pharmaxis discoveries to get a a$1.4 million boost to advance cancer and skin disease treatments
Pharmaxis Ltd's drug discoveries have been given a boost after the Australian government awarded two grants totalling A$1.4 million to respected scie...
January 6, 2022, 12:21 am